Navigation Links
Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
Date:6/2/2011

PLANTATION, Fla. and MONTREAL, June 2, 2011 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI), a full service CMO focused on process development and GMP manufacturing of cell culture derived biopharmaceuticals, and Alethia Biotherapeutics, Inc., a biotechnology company focused on monoclonal antibody development with a very sensitive and highly disease-tissue specific proprietary target discovery platform, announced a collaboration on the development of a mammalian cell line-based IgG monoclonal antibody project that is anticipated to make a significant impact in the treatment of selected cancers. Terms of the agreement were not disclosed.

"AB-16B5 is a humanized IgG2 monoclonal antibody which targets secreted clusterin for the inhibition of cancer-associated epithelial-to-mesenchymal transition (EMT), and it has shown positive pre-clinical results in representative cancer models derived from various solid tumors," notes Mario Filion, Ph.D., Executive VP and CSO at Alethia Biotherapeutics. "And, we are pleased to select GBI as our development and GMP manufacturing partner for our first product candidate."

"We at GBI would like to echo that comment. We are pleased to partner with Alethia Biotherapeutics on this important project," says SooYoung Lee, PhD and Senior Vice President of Operations at GBI. "In the biologics CMO niche, we were among the first to engineer the concept of 'full integration', which enables us to work with our clients from Proof of Concept through the manufacture of pre-clinical, and clinical trial products. It is a process we termed 'GMPnization'. In other words, we begin with the end in mind. We employ appropriate stringent regulatory and quality systems to supply product candidates during the development cycle from the initial 'production' cell line development all the way through scale up steps leading to the final cGMP compliant manufacturing process and vialing of the final biopharmaceutical product."

Abou
'/>"/>

SOURCE Goodwin Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
3. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
4. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
5. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
6. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
7. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
8. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
9. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
10. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
11. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... WASHINGTON , March 27, 2015 ... - The biopharmaceutical industry comes out on top as ... in a new report  from ndp│analytics. According to ... and development (R&D) investment over the last decade, accounting ... 2000-2012. A Short Video on ...
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today ... at 1802 South First St. in the Temple Medical and ... City of Temple to receive funding for ... Texas Veterans Health Care System, the new facility will enable ... biotechnology and life science companies. ...
(Date:3/27/2015)... , March 27, 2015 A new report ... Latin America – Chile , ... are top targets for IVD firms.  The healthcare research ... heavily into IVD strategies for the Latin American continent with ... support globally distributed supply operations. However, the country,s regional economic ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... SAN DIEGO, Nov. 16 CareFusion (NYSE: ... announced a Web-based application that provides hospitals with on-demand ... costs. , The CareFusion Knowledge Portal is a remotely ... information dashboard to review metrics and actionable data directly ...
... Nov. 16 Personalized Pharmaceutical Systems (PPS) today announced ... Viropharma Incorporated. , PPS is a clinical trial ... technology in phenomics to help drug companies identify the ... help patients get the right drug the first time. ...
Cached Medicine Technology:CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 2CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 3Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated 2
(Date:3/28/2015)... 2015 Take a bite of warm, ... action. Acids tumble into the stomach, ready to break ... structure lets these acids run amok, triggering a burning ... symptom. More than 60 million Americans have heartburn at ... heartburn starts, and how it can be stopped. , ...
(Date:3/28/2015)... 2015 The California-based leading wig brand ... customer shopping on UniWigs during the Easter Holidays from ... big promotion on April Fools’ Day. , As the ... around the corner. Easter Festival, with religious origins to ... major holiday after Christmas. The best wig provider, UniWigs, ...
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... experiences re-injury, according to research presented today at the ... Specialty Day. The study examined the long term success ... , “We examined survey data from 242 patients ... lead author Justin P. Roe, MBBS, FRACS, from North ...
(Date:3/28/2015)... Early surgery may not be the best ... injuries, according to new research from Tripler Army Medical ... Society for Sports Medicine’s ( AOSSM ) Specialty Day, ... was not performed. , The final study group focused ... 17 receiving non-surgical therapy. Of the non-surgery group, 8 ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2
... medication and reduce risk of ... medication errors, ... move to continually improve patient safety,and staff efficiency, Omnicell, Inc. (Nasdaq: ... facilities, and Grant Regional Health,Center, a leading healthcare provider, today announced ...
... the,appointment of Bryan R. Rogers as President of HCA,s ... Jan. 1, 2008. Rogers replaces Tom,May who recently announced ... will have responsibility for,operations in Nevada, California and Alaska, ... with annual net revenues of,$2.5 billion. He currently ...
... Lead Life Insurance Wholesaling to Company,s Retail Distribution ... Kahal has joined AXA,Equitable as National Sales Manager ... CT. The announcement was made,today by Jamie Shepherdson, ... and annuity wholesale distribution organization. Mr. Kahal,will report ...
... Researchers at the American University of ... that administering a lidocaine lollipop as a single-agent ... endoscopy procedure eliminated the need for sedation in ... in the October issue of Gastrointestinal Endoscopy, the ...
... who couple classroom courses with behind-the-wheel training can significantly ... in the latest issue of The Journal of ... A recent study spearheaded by Yale University,s Richard Marottoli ... underwent eight hours of classroom instruction and two hours ...
... Global Med Technologies(R),Inc. (OTC Bulletin Board: GLOB), ... that it will report its,third quarter results on ... Company will host a conference call at 4:30 ... http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Conference Call Details: ...
Cached Medicine News:Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 2Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 3Health News:Bryan R. Rogers Appointed President of Far West Division 2Health News:David Kahal Joins AXA Equitable as National Sales Manager 2Health News:Patients may have sweet and effective way to prepare for upper GI endoscopy: an anesthetic lollipop 2Health News:Patients may have sweet and effective way to prepare for upper GI endoscopy: an anesthetic lollipop 3Health News:Global Med Technologies(R) Inc. to Announce Third Quarter Results On October 30th - Conference Call to Follow Release 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: